Zack Lynch serves as Executive at Pear Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Zack Lynch has executed 3 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Dec 3, 2021 involved receiving (via award) 10,000 shares valued at $100.0K.
Zack Lynch currently holds 9,681,673 shares of Pear Therapeutics, Inc. (PEAR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Zack Lynch has been a net neutral trader of PEAR stock. They have purchased $0 and sold $0 worth of shares.
Zack Lynch's most recent insider trade was on Dec 3, 2021, when they sold 10,000 shares at $10.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Dec 3, 2021 | PEAR | $0 | Award | 9,671,673 | $N/A | Discretionary |